NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|981344715|ref|WP_059560428|]
View 

M1 family metallopeptidase [Burkholderia vietnamiensis]

Protein Classification

M1 family metallopeptidase( domain architecture ID 11416872)

M1 family metallopeptidase contains an active site with a catalytic zinc ion bound by two histidines and a glutamate present in an HEXXH motif; functions as an aminopeptidase

EC:  3.4.-.-
MEROPS:  M1
PubMed:  10493853

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
67-620 1.85e-118

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


:

Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 368.20  E-value: 1.85e-118
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715  67 LPDTVVPVNYRLWFRPNEALNAFDGRADVEIKVLKPVNN-IVIAGHRIKFTNGRITLQPgniqliATPQDKGDFYQLRPA 145
Cdd:COG0308   11 RPPGYDVTHYDLDLDLDPATTRLSGTATITFTATEAPLDsLVLDLKGLEVTSVTVDGKP------LDFTRDGERLTITLP 84
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 146 AGTIAPGNYSLHMEWSGIINfksyddpvnhtggscgddpypgcSAAEGVFRVdlkSTDGTTSGAILTQGETNLARQWFPG 225
Cdd:COG0308   85 KPLAPGETFTLEIEYSGKPS-----------------------NGGEGLYRS---GDPPDGPPYLYTQCEPEGARRWFPC 138
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 226 WDEPAFRPTYEVTAEVPQNWRVVSNAAEKPSTNVGGGYKLVQFEKTPPMPSYLLFFGGGMFDTYEDNFTSPLPgakgslh 305
Cdd:COG0308  139 FDHPDDKATFTLTVTVPAGWVAVSNGNLVSETELGDGRTTWHWADTQPIPTYLFALAAGDYAVVEDTFASGVP------- 211
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 306 LRVFTPPGMSDWAKPAMDRTKQALDFYYRYTGIPLPLTKFDTVAANdafkeqkDLNFGGMENWGSILeFADDILPQPGQP 385
Cdd:COG0308  212 LRVYVRPGLADKAKEAFESTKRMLDFFEELFGVPYPFDKYDQVAVP-------DFNFGAMENQGLVT-FGEKVLADETAT 283
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 386 MSHYGN--EVLTHEVAHQWFGDLVTTDWWDNVWLNESFATFFENKTTIQFFPDEFsWLDQVKNKYR--VINRDIGPNAFP 461
Cdd:COG0308  284 DADYERreSVIAHELAHQWFGNLVTCADWDDLWLNEGFATYMEQLFSEDLYGKDA-ADRIFVGALRsyAFAEDAGPNAHP 362
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 462 VAPNFNDWASNDFvlsaSAFTYDKGGHVLKTLENYLGEQTLRKGLQQYLVDYSFGNGTPKRLWDELSKASGQPVGPIGDS 541
Cdd:COG0308  363 IRPDDYPEIENFF----DGIVYEKGALVLHMLRTLLGDEAFRAGLRLYFARHAGGNATTEDFLAALEEASGRDLSAFFDQ 438
                        490       500       510       520       530       540       550
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 981344715 542 YVRQTGVPLVTLDTQCDmTKNQTIVTLKQQPFPNtnaypgLQWTVPITLAYGQGLAQRTTLALkdTQAQTRVDGCTGVV 620
Cdd:COG0308  439 WLYQAGLPTLEVEYEYD-ADGKVTLTLRQTPPRP------HPFHIPLEVGLLGGKLTARTVLL--DGEQTELVAKPDPV 508
 
Name Accession Description Interval E-value
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
67-620 1.85e-118

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 368.20  E-value: 1.85e-118
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715  67 LPDTVVPVNYRLWFRPNEALNAFDGRADVEIKVLKPVNN-IVIAGHRIKFTNGRITLQPgniqliATPQDKGDFYQLRPA 145
Cdd:COG0308   11 RPPGYDVTHYDLDLDLDPATTRLSGTATITFTATEAPLDsLVLDLKGLEVTSVTVDGKP------LDFTRDGERLTITLP 84
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 146 AGTIAPGNYSLHMEWSGIINfksyddpvnhtggscgddpypgcSAAEGVFRVdlkSTDGTTSGAILTQGETNLARQWFPG 225
Cdd:COG0308   85 KPLAPGETFTLEIEYSGKPS-----------------------NGGEGLYRS---GDPPDGPPYLYTQCEPEGARRWFPC 138
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 226 WDEPAFRPTYEVTAEVPQNWRVVSNAAEKPSTNVGGGYKLVQFEKTPPMPSYLLFFGGGMFDTYEDNFTSPLPgakgslh 305
Cdd:COG0308  139 FDHPDDKATFTLTVTVPAGWVAVSNGNLVSETELGDGRTTWHWADTQPIPTYLFALAAGDYAVVEDTFASGVP------- 211
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 306 LRVFTPPGMSDWAKPAMDRTKQALDFYYRYTGIPLPLTKFDTVAANdafkeqkDLNFGGMENWGSILeFADDILPQPGQP 385
Cdd:COG0308  212 LRVYVRPGLADKAKEAFESTKRMLDFFEELFGVPYPFDKYDQVAVP-------DFNFGAMENQGLVT-FGEKVLADETAT 283
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 386 MSHYGN--EVLTHEVAHQWFGDLVTTDWWDNVWLNESFATFFENKTTIQFFPDEFsWLDQVKNKYR--VINRDIGPNAFP 461
Cdd:COG0308  284 DADYERreSVIAHELAHQWFGNLVTCADWDDLWLNEGFATYMEQLFSEDLYGKDA-ADRIFVGALRsyAFAEDAGPNAHP 362
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 462 VAPNFNDWASNDFvlsaSAFTYDKGGHVLKTLENYLGEQTLRKGLQQYLVDYSFGNGTPKRLWDELSKASGQPVGPIGDS 541
Cdd:COG0308  363 IRPDDYPEIENFF----DGIVYEKGALVLHMLRTLLGDEAFRAGLRLYFARHAGGNATTEDFLAALEEASGRDLSAFFDQ 438
                        490       500       510       520       530       540       550
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 981344715 542 YVRQTGVPLVTLDTQCDmTKNQTIVTLKQQPFPNtnaypgLQWTVPITLAYGQGLAQRTTLALkdTQAQTRVDGCTGVV 620
Cdd:COG0308  439 WLYQAGLPTLEVEYEYD-ADGKVTLTLRQTPPRP------HPFHIPLEVGLLGGKLTARTVLL--DGEQTELVAKPDPV 508
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
74-544 1.88e-110

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 341.87  E-value: 1.88e-110
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715  74 VNYRLWFRPNEALNAFDGRADVEIKVLKPVNNIVIAGHRIKFTNGRITLQPGNIQLIATPQDKGDFYQLR-PAAGTIAPG 152
Cdd:cd09601    1 LHYDLTLTPDLENFTFSGSVTITLEVLEPTDTIVLHAKDLTITSASLTLKGGSGIIEVTVVTDEETEFLTiTLDETLPPG 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 153 -NYSLHMEWSGIINfksyddpvnhtggscgDDPYpgcsaaeGVFRVDLKSTDGTTSGAILTQGETNLARQWFPGWDEPAF 231
Cdd:cd09601   81 eNYTLSIEFTGKLN----------------DDLR-------GFYRSSYTDEDGETRYLAATQFEPTDARRAFPCFDEPAF 137
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 232 RPTYEVTAEVPQNWRVVSNAAEKPSTNVGGGYKLVQFEKTPPMPSYLLFFGGGMFDTYEDNFTSPLPgakgslhLRVFTP 311
Cdd:cd09601  138 KATFDITITHPKGYTALSNMPPVESTELEDGWKTTTFETTPPMSTYLVAFVVGDFEYIESTTKSGVP-------VRVYAR 210
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 312 PGMSDWAKPAMDRTKQALDFYYRYTGIPLPLTKFDTVAANdafkeqkDLNFGGMENWGSILeFADDIL---PQPGQPMSH 388
Cdd:cd09601  211 PGKIEQGDFALEVAPKILDFYEDYFGIPYPLPKLDLVAIP-------DFAAGAMENWGLIT-YRETALlydPKTSSASDK 282
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 389 YGN-EVLTHEVAHQWFGDLVTTDWWDNVWLNESFATFFENKTTIQFFPD-EFSWLDQVKNKYRVINRDIGPNAFPVAPNF 466
Cdd:cd09601  283 QRVaEVIAHELAHQWFGNLVTMKWWDDLWLNEGFATYMEYLAVDKLFPEwNMWDQFVVDELQSALELDSLASSHPIEVPV 362
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 467 NDWA--SNDFvlsaSAFTYDKGGHVLKTLENYLGEQTLRKGLQQYLVDYSFGNGTPKRLWDELSKASGQ----PVGPIGD 540
Cdd:cd09601  363 ESPSeiSEIF----DAISYSKGASVLRMLENFLGEEVFRKGLRKYLKKHAYGNATTDDLWEALQEASGEskplDVKEIMD 438

                 ....
gi 981344715 541 SYVR 544
Cdd:cd09601  439 SWTL 442
pepN_strep_liv TIGR02412
aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the ...
192-558 1.30e-55

aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the zinc metallopeptidase family M1 (pfam01433), with a single member characterized in Streptomyces lividans 66 and designated aminopeptidase N. The spectrum of activity may differ somewhat from the aminopeptidase N clade of E. coli and most other Proteobacteria, well separated phylogenetically within the M1 family. The M1 family also includes leukotriene A-4 hydrolase/aminopeptidase (with a bifunctional active site).


Pssm-ID: 274121 [Multi-domain]  Cd Length: 831  Bit Score: 204.25  E-value: 1.30e-55
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715  192 EGVFR-VDlkSTDGTTSgaILTQGETNLARQWFPGWDEPAFRPTYEVTAEVPQNWRVVSNAAEKPSTNVGGGyKLVQFEK 270
Cdd:TIGR02412 105 EGLHRfVD--PVDGEVY--LYTQFEPADARRVFAVFDQPDLKANFKFSVKAPEDWTVISNSRETDVTPEPAD-RRWEFPE 179
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715  271 TPPMPSYLLFFGGGMFDTYEDNftsplpgaKGSLHLRVFTPPGMSDW--AKPAMDRTKQALDFYYRYTGIPLPLTKFDTV 348
Cdd:TIGR02412 180 TPKLSTYLTAVAAGPYHSVQDE--------SRSYPLGIYARRSLAQYldADAIFTITRQGLAFFHRKFGYPYPFKKYDQI 251
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715  349 AAndafkeqKDLNFGGMENWGSIlEFADDILPQPGQPMSHYGNEVLT--HEVAHQWFGDLVTTDWWDNVWLNESFATFFE 426
Cdd:TIGR02412 252 FV-------PEFNAGAMENAGCV-TFAENFLHRAEATRAEKENRAGVilHEMAHMWFGDLVTMRWWNDLWLNESFAEYMG 323
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715  427 NKTTIQF--FPDefSWLD-QVKNKYRVINRDIGPNAFPVAPNFNDWAsnDFVLSASAFTYDKGGHVLKTLENYLGEQTLR 503
Cdd:TIGR02412 324 TLASAEAteYTD--AWTTfAAQGKQWAYEADQLPTTHPIVADVADLA--DALSNFDGITYAKGASVLKQLVAWVGEEAFF 399
                         330       340       350       360       370
                  ....*....|....*....|....*....|....*....|....*....|....*
gi 981344715  504 KGLQQYLVDYSFGNGTPKRLWDELSKASGQPVGPIGDSYVRQTGVPLVTLDTQCD 558
Cdd:TIGR02412 400 AGVNAYFKRHAFGNATLDDLIDSLAKASGRDLSAWSDAWLETAGVNTLTPEITTD 454
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
321-542 4.56e-48

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 169.01  E-value: 4.56e-48
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715  321 AMDRTKQALDFYYRYTGIPLPLTKFDTVAAndafkeqKDLNFGGMENWGSILEFADDILPQPGQ-PMSHYGN--EVLTHE 397
Cdd:pfam01433   2 ALEITVKLLEFYEDYFNIPYPLPKYDLVAL-------PDFSAGAMENWGLITYRETLLLYDPGNsSTSDKQRvaSVIAHE 74
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715  398 VAHQWFGDLVTTDWWDNVWLNESFATFFENKTTIQFFPDEFSWLD-QVKNKYRVINRDIGPNAFPVAPNFNDWASNDFVL 476
Cdd:pfam01433  75 LAHQWFGNLVTMKWWDDLWLNEGFATYMEYLGTDALFPEWNIWEQfLLDEVQNAMARDALDSSHPITQNVNDPSEIDDIF 154
                         170       180       190       200       210       220
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 981344715  477 saSAFTYDKGGHVLKTLENYLGEQTLRKGLQQYLVDYSFGNGTPKRLWDELSKASG-QPVGPIGDSY 542
Cdd:pfam01433 155 --DAIPYEKGASVLRMLETLLGEEVFQKGLRSYLKKFQYGNATTEDLWDALSEASGpLDVDSFMDTW 219
 
Name Accession Description Interval E-value
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
67-620 1.85e-118

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 368.20  E-value: 1.85e-118
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715  67 LPDTVVPVNYRLWFRPNEALNAFDGRADVEIKVLKPVNN-IVIAGHRIKFTNGRITLQPgniqliATPQDKGDFYQLRPA 145
Cdd:COG0308   11 RPPGYDVTHYDLDLDLDPATTRLSGTATITFTATEAPLDsLVLDLKGLEVTSVTVDGKP------LDFTRDGERLTITLP 84
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 146 AGTIAPGNYSLHMEWSGIINfksyddpvnhtggscgddpypgcSAAEGVFRVdlkSTDGTTSGAILTQGETNLARQWFPG 225
Cdd:COG0308   85 KPLAPGETFTLEIEYSGKPS-----------------------NGGEGLYRS---GDPPDGPPYLYTQCEPEGARRWFPC 138
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 226 WDEPAFRPTYEVTAEVPQNWRVVSNAAEKPSTNVGGGYKLVQFEKTPPMPSYLLFFGGGMFDTYEDNFTSPLPgakgslh 305
Cdd:COG0308  139 FDHPDDKATFTLTVTVPAGWVAVSNGNLVSETELGDGRTTWHWADTQPIPTYLFALAAGDYAVVEDTFASGVP------- 211
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 306 LRVFTPPGMSDWAKPAMDRTKQALDFYYRYTGIPLPLTKFDTVAANdafkeqkDLNFGGMENWGSILeFADDILPQPGQP 385
Cdd:COG0308  212 LRVYVRPGLADKAKEAFESTKRMLDFFEELFGVPYPFDKYDQVAVP-------DFNFGAMENQGLVT-FGEKVLADETAT 283
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 386 MSHYGN--EVLTHEVAHQWFGDLVTTDWWDNVWLNESFATFFENKTTIQFFPDEFsWLDQVKNKYR--VINRDIGPNAFP 461
Cdd:COG0308  284 DADYERreSVIAHELAHQWFGNLVTCADWDDLWLNEGFATYMEQLFSEDLYGKDA-ADRIFVGALRsyAFAEDAGPNAHP 362
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 462 VAPNFNDWASNDFvlsaSAFTYDKGGHVLKTLENYLGEQTLRKGLQQYLVDYSFGNGTPKRLWDELSKASGQPVGPIGDS 541
Cdd:COG0308  363 IRPDDYPEIENFF----DGIVYEKGALVLHMLRTLLGDEAFRAGLRLYFARHAGGNATTEDFLAALEEASGRDLSAFFDQ 438
                        490       500       510       520       530       540       550
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 981344715 542 YVRQTGVPLVTLDTQCDmTKNQTIVTLKQQPFPNtnaypgLQWTVPITLAYGQGLAQRTTLALkdTQAQTRVDGCTGVV 620
Cdd:COG0308  439 WLYQAGLPTLEVEYEYD-ADGKVTLTLRQTPPRP------HPFHIPLEVGLLGGKLTARTVLL--DGEQTELVAKPDPV 508
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
74-544 1.88e-110

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 341.87  E-value: 1.88e-110
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715  74 VNYRLWFRPNEALNAFDGRADVEIKVLKPVNNIVIAGHRIKFTNGRITLQPGNIQLIATPQDKGDFYQLR-PAAGTIAPG 152
Cdd:cd09601    1 LHYDLTLTPDLENFTFSGSVTITLEVLEPTDTIVLHAKDLTITSASLTLKGGSGIIEVTVVTDEETEFLTiTLDETLPPG 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 153 -NYSLHMEWSGIINfksyddpvnhtggscgDDPYpgcsaaeGVFRVDLKSTDGTTSGAILTQGETNLARQWFPGWDEPAF 231
Cdd:cd09601   81 eNYTLSIEFTGKLN----------------DDLR-------GFYRSSYTDEDGETRYLAATQFEPTDARRAFPCFDEPAF 137
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 232 RPTYEVTAEVPQNWRVVSNAAEKPSTNVGGGYKLVQFEKTPPMPSYLLFFGGGMFDTYEDNFTSPLPgakgslhLRVFTP 311
Cdd:cd09601  138 KATFDITITHPKGYTALSNMPPVESTELEDGWKTTTFETTPPMSTYLVAFVVGDFEYIESTTKSGVP-------VRVYAR 210
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 312 PGMSDWAKPAMDRTKQALDFYYRYTGIPLPLTKFDTVAANdafkeqkDLNFGGMENWGSILeFADDIL---PQPGQPMSH 388
Cdd:cd09601  211 PGKIEQGDFALEVAPKILDFYEDYFGIPYPLPKLDLVAIP-------DFAAGAMENWGLIT-YRETALlydPKTSSASDK 282
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 389 YGN-EVLTHEVAHQWFGDLVTTDWWDNVWLNESFATFFENKTTIQFFPD-EFSWLDQVKNKYRVINRDIGPNAFPVAPNF 466
Cdd:cd09601  283 QRVaEVIAHELAHQWFGNLVTMKWWDDLWLNEGFATYMEYLAVDKLFPEwNMWDQFVVDELQSALELDSLASSHPIEVPV 362
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 467 NDWA--SNDFvlsaSAFTYDKGGHVLKTLENYLGEQTLRKGLQQYLVDYSFGNGTPKRLWDELSKASGQ----PVGPIGD 540
Cdd:cd09601  363 ESPSeiSEIF----DAISYSKGASVLRMLENFLGEEVFRKGLRKYLKKHAYGNATTDDLWEALQEASGEskplDVKEIMD 438

                 ....
gi 981344715 541 SYVR 544
Cdd:cd09601  439 SWTL 442
M1_APN cd09602
Peptidase M1 family including aminopeptidase N catalytic domain; This model represents the ...
212-533 2.39e-69

Peptidase M1 family including aminopeptidase N catalytic domain; This model represents the catalytic domain of bacterial and eukaryotic aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341065 [Multi-domain]  Cd Length: 440  Bit Score: 233.95  E-value: 2.39e-69
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 212 TQGETNLARQWFPGWDEPAFRPTYEVTAEVPQNWRVVSNAAEKPSTNvGGGYKLVQFEKTPPMPSYLLFFGGGMFDTYED 291
Cdd:cd09602  120 TLFEPDDARRVFPCFDQPDLKATFTLTVTAPADWTVISNGPETSTEE-AGGRKRWRFAETPPLSTYLFAFVAGPYHRVED 198
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 292 NftsplpgaKGSLHLRVFTPPGMSDWAKPA---MDRTKQALDFYYRYTGIPLPLTKFDTVAANDafkeqkdLNFGGMENW 368
Cdd:cd09602  199 E--------HDGIPLGLYCRESLAEYERDAdeiFEVTKQGLDFYEDYFGIPYPFGKYDQVFVPE-------FNFGAMENP 263
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 369 GSILeFADDILPQPGQPMSHYGN--EVLTHEVAHQWFGDLVTTDWWDNVWLNESFATFFENKTTIQFFPDEFSWLDQVKN 446
Cdd:cd09602  264 GAVT-FRESYLFREEPTRAQRLRraNTILHEMAHMWFGDLVTMKWWDDLWLNESFADFMAAKALAEATPFTDAWLTFLLR 342
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 447 K----YRVinrDIGPNAFPVA---PNFNDwASNDFvlsaSAFTYDKGGHVLKTLENYLGEQTLRKGLQQYLVDYSFGNGT 519
Cdd:cd09602  343 RkpwaYRA---DQLPTTHPIAqdvPDLEA-AGSNF----DGITYAKGASVLKQLVALVGEEAFRAGLREYFKKHAYGNAT 414
                        330
                 ....*....|....
gi 981344715 520 PKRLWDELSKASGQ 533
Cdd:cd09602  415 LDDLIAALDEASGR 428
M1 cd09595
Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 ...
202-529 3.42e-62

Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 hydrolase; The model represents the catalytic domains of M1 peptidase family members including aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). All peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile upon activation during catalysis. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. APN expression is dysregulated in many inflammatory diseases and is enhanced in numerous tumor cells, making it a lead target in the development of anti-cancer and anti-inflammatory drugs. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase in LTA4H is as yet unknown, while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals.


Pssm-ID: 341058 [Multi-domain]  Cd Length: 413  Bit Score: 213.85  E-value: 3.42e-62
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 202 TDGTTSGAILTQGETNLARQWFPGWDEPAFRPTYEVTAEVPQNWRVVSNAAEKPSTNVGGGYKLVQFEKTPPMPSYLLFF 281
Cdd:cd09595   99 TAGKEKPYLFTQFEATHARRIFPCIDHPAVKATFTVTITTPKKDLLASNGALVGEETGANGRKTYRFEDTPPIPTYLVAV 178
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 282 GGGMFDTYEDNFTSplpgaKGSLHLRVFTPPGMSDWAKPAMDRTKQALDFYYRYTGIPLPLTKFDTVAAndafkeqKDLN 361
Cdd:cd09595  179 VVGDLEFKYVTVKS-----QPRVGLSVYSEPLQVDQAQYAFDATRAALAWFEDYFGGPYPLPKYDLLAV-------PDFN 246
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 362 FGGMENWGSILEFADDILPQPGQPMSHYGNEVLT-HEVAHQWFGDLVTTDWWDNVWLNESFATFFENKTTIQFFPDEFSW 440
Cdd:cd09595  247 SGAMENPGLITFRTTYLLRSKVTDTGARSIENVIaHELAHQWFGNLVTMRWWNDLWLNEGFAVYYENRIMDATFGTSSRH 326
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 441 LDQVKNkYRVINRDIGPN--AFPVAPNFNDWASNDFVlsaSAFTYDKGGHVLKTLENYLGEQTLRKGLQQYLVDYSFGNG 518
Cdd:cd09595  327 LDQLSG-SSDLNTEQLLEdsSPTSTPVRSPADPDVAY---DGVTYAKGALVLRMLEELVGEEAFDKGVQAYFNRHKFKNA 402
                        330
                 ....*....|.
gi 981344715 519 TPKRLWDELSK 529
Cdd:cd09595  403 TTDDFIDALEE 413
pepN_strep_liv TIGR02412
aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the ...
192-558 1.30e-55

aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the zinc metallopeptidase family M1 (pfam01433), with a single member characterized in Streptomyces lividans 66 and designated aminopeptidase N. The spectrum of activity may differ somewhat from the aminopeptidase N clade of E. coli and most other Proteobacteria, well separated phylogenetically within the M1 family. The M1 family also includes leukotriene A-4 hydrolase/aminopeptidase (with a bifunctional active site).


Pssm-ID: 274121 [Multi-domain]  Cd Length: 831  Bit Score: 204.25  E-value: 1.30e-55
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715  192 EGVFR-VDlkSTDGTTSgaILTQGETNLARQWFPGWDEPAFRPTYEVTAEVPQNWRVVSNAAEKPSTNVGGGyKLVQFEK 270
Cdd:TIGR02412 105 EGLHRfVD--PVDGEVY--LYTQFEPADARRVFAVFDQPDLKANFKFSVKAPEDWTVISNSRETDVTPEPAD-RRWEFPE 179
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715  271 TPPMPSYLLFFGGGMFDTYEDNftsplpgaKGSLHLRVFTPPGMSDW--AKPAMDRTKQALDFYYRYTGIPLPLTKFDTV 348
Cdd:TIGR02412 180 TPKLSTYLTAVAAGPYHSVQDE--------SRSYPLGIYARRSLAQYldADAIFTITRQGLAFFHRKFGYPYPFKKYDQI 251
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715  349 AAndafkeqKDLNFGGMENWGSIlEFADDILPQPGQPMSHYGNEVLT--HEVAHQWFGDLVTTDWWDNVWLNESFATFFE 426
Cdd:TIGR02412 252 FV-------PEFNAGAMENAGCV-TFAENFLHRAEATRAEKENRAGVilHEMAHMWFGDLVTMRWWNDLWLNESFAEYMG 323
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715  427 NKTTIQF--FPDefSWLD-QVKNKYRVINRDIGPNAFPVAPNFNDWAsnDFVLSASAFTYDKGGHVLKTLENYLGEQTLR 503
Cdd:TIGR02412 324 TLASAEAteYTD--AWTTfAAQGKQWAYEADQLPTTHPIVADVADLA--DALSNFDGITYAKGASVLKQLVAWVGEEAFF 399
                         330       340       350       360       370
                  ....*....|....*....|....*....|....*....|....*....|....*
gi 981344715  504 KGLQQYLVDYSFGNGTPKRLWDELSKASGQPVGPIGDSYVRQTGVPLVTLDTQCD 558
Cdd:TIGR02412 400 AGVNAYFKRHAFGNATLDDLIDSLAKASGRDLSAWSDAWLETAGVNTLTPEITTD 454
M1_APN_like cd09603
Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly ...
75-544 1.24e-54

Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly bacterial and some archaeal M1 peptidases with smilarity to the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341066 [Multi-domain]  Cd Length: 410  Bit Score: 193.18  E-value: 1.24e-54
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715  75 NYRLWFRPNEALNAFDGRADVEIKVLKP------------VNNIVIAGHRIKF---TNGRITLQPgniqliATPQDKGD- 138
Cdd:cd09603    5 HYDLDLDYDPATKSLSGTATITFRATQDldslqldlvgltVSSVTVDGVPAAFfthDGDKLVITL------PRPLAAGEt 78
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 139 -----FYQLRPAAGTIAPGNYSlhmewsgiinfksyddpvnhtggscgddpypgcsaaegvfrvdlksTDGTTSGAILTQ 213
Cdd:cd09603   79 ftvtvRYSGKPRPAGYPPGDGG----------------------------------------------GWEEGDDGVWTA 112
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 214 GETNLARQWFPGWDEPAFRPTYEVTAEVPQNWRVVSNAAEKPSTNVGGGYKLVQFEKTPPMPSYLLFFGGGMFDTYEDnf 293
Cdd:cd09603  113 GQPEGASTWFPCNDHPDDKATYDITVTVPAGLTVVSNGRLVSTTTNGGGTTTWHWKMDYPIATYLVTLAVGRYAVVED-- 190
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 294 tsplpGAKGSLHLRVFTPPGMSDWAKPAMDRTKQALDFYYRYtGIPLPLTKFDTVAANDafkeqkdlNFGGMENwgsile 373
Cdd:cd09603  191 -----GSGGGIPLRYYVPPGDAAKAKASFARTPEMLDFFEEL-FGPYPFEKYGQVVVPD--------LGGGMEH------ 250
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 374 faddilpqpgQPMSHYGNEVLT----------HEVAHQWFGDLVTTDWWDNVWLNESFATFFENKTTIQFFPDEfSWLDQ 443
Cdd:cd09603  251 ----------QTATTYGNNFLNgdrgserliaHELAHQWFGDSVTCADWADIWLNEGFATYAEWLWSEHKGGAD-AYRAY 319
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 444 VKNKYR-VINRDIGPNAFPVAPNFNDWAsndfvlsasafTYDKGGHVLKTLENYLGEQTLRKGLQQYLVDYSFGNGTPKR 522
Cdd:cd09603  320 LAGQRQdYLNADPGPGRPPDPDDLFDRD-----------VYQKGALVLHMLRNLLGDEAFFAALRAYLARYAHGNVTTED 388
                        490       500
                 ....*....|....*....|..
gi 981344715 523 LWDELSKASGQPVGPIGDSYVR 544
Cdd:cd09603  389 FIAAAEEVSGRDLTWFFDQWLY 410
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
321-542 4.56e-48

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 169.01  E-value: 4.56e-48
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715  321 AMDRTKQALDFYYRYTGIPLPLTKFDTVAAndafkeqKDLNFGGMENWGSILEFADDILPQPGQ-PMSHYGN--EVLTHE 397
Cdd:pfam01433   2 ALEITVKLLEFYEDYFNIPYPLPKYDLVAL-------PDFSAGAMENWGLITYRETLLLYDPGNsSTSDKQRvaSVIAHE 74
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715  398 VAHQWFGDLVTTDWWDNVWLNESFATFFENKTTIQFFPDEFSWLD-QVKNKYRVINRDIGPNAFPVAPNFNDWASNDFVL 476
Cdd:pfam01433  75 LAHQWFGNLVTMKWWDDLWLNEGFATYMEYLGTDALFPEWNIWEQfLLDEVQNAMARDALDSSHPITQNVNDPSEIDDIF 154
                         170       180       190       200       210       220
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 981344715  477 saSAFTYDKGGHVLKTLENYLGEQTLRKGLQQYLVDYSFGNGTPKRLWDELSKASG-QPVGPIGDSY 542
Cdd:pfam01433 155 --DAIPYEKGASVLRMLETLLGEEVFQKGLRSYLKKFQYGNATTEDLWDALSEASGpLDVDSFMDTW 219
M1_APN_like cd09604
Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains ...
213-533 2.62e-29

Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains bacterial M1 peptidases with smilarity to the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341067 [Multi-domain]  Cd Length: 440  Bit Score: 121.61  E-value: 2.62e-29
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 213 QGETNLArQWFP--------GWDEPAFRP----------TYEVTAEVPQNWRVVSNAAEKPSTNVGGGYKLVQFeKTPPM 274
Cdd:cd09604  124 GDEYNLA-QWYPklavyddgGWNTDPYYGrgeffysdfgDYDVTITVPKNYVVAATGELQNPEEVLDGTKTWHF-KAENV 201
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 275 PSYLLFFGggmfdtyeDNFTSpLPGAKGSLHLRVFTPPGMSDWAKPAMDRTKQALDFYYRYTGiPLPLTKFDTVAAndaf 354
Cdd:cd09604  202 RDFAWAAS--------PDFVV-DAATVDGVTVNVYYLPENAEAAERALEYAKDALEFFSEKFG-PYPYPELDVVQG---- 267
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 355 keqkDLNFGGMENWGSIleFADDILPQPGQpmshYGNEVLTHEVAHQWFGDLVTTDWWDNVWLNESFATFFENKTTIQFF 434
Cdd:cd09604  268 ----PFGGGGMEYPGLV--FIGSRLYDPKR----SLEGVVVHEIAHQWFYGIVGNDERREPWLDEGLATYAESLYLEEKY 337
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 435 PDEFSWLDQVKNKYRVINRDIG-PNAFPVaPNFNDWasndfvLSASAFTYDKGGHVLKTLENYLGEQTLRKGLQQYLVDY 513
Cdd:cd09604  338 GKEAADELLGRRYYRAYARGPGgPINLPL-DTFPDG------SYYSNAVYSKGALFLEELREELGDEAFDKALREYYRRY 410
                        330       340
                 ....*....|....*....|
gi 981344715 514 SFGNGTPKRLWDELSKASGQ 533
Cdd:cd09604  411 KFKHPTPEDFFRTAEEVSGK 430
Peptidase_M1_N pfam17900
Peptidase M1 N-terminal domain; This domain is found at the N-terminus of aminopeptidases from ...
72-278 1.36e-27

Peptidase M1 N-terminal domain; This domain is found at the N-terminus of aminopeptidases from the M1 family.


Pssm-ID: 465557 [Multi-domain]  Cd Length: 186  Bit Score: 110.13  E-value: 1.36e-27
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715   72 VPVNYRLWFRPNEALNAFDGRADVEIKVLKPVNNIVIAGHRIKFTNGRITLQPGNIQLIAT---PQDKGDFYQLRPAAGT 148
Cdd:pfam17900   1 VPEHYDLDLKIDLKNFTFSGSVTITLQLNNATNVIVLHASDLTIRSISLSDEVTSDGVPADfteDQKDGEKLTIVLPETL 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715  149 IAPGNYSLHMEWSGIINfksyddpvnhtggscgdDPYpgcsaaEGVFRVDLKsTDGTTSGAILTQGETNLARQWFPGWDE 228
Cdd:pfam17900  81 NQTGPYTLEIEYSGELN-----------------DSM------TGFYRSTYT-DNGEKKVLVTTQFEPTDARSAFPCFDE 136
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|
gi 981344715  229 PAFRPTYEVTAEVPQNWRVVSNAAEKPSTNVGGGYKLVQFEKTPPMPSYL 278
Cdd:pfam17900 137 PSVKATFTISIIHPKDYTALSNMPVIASEPLENGWVITTFEQTPKMSTYL 186
M1_LTA4H cd09599
Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents ...
212-515 3.84e-21

Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents the N-terminal catalytic domain of leukotriene A4 hydrolase (LTA4H; E.C. 3.3.2.6) and the close homolog cold-active aminopeptidase (Colwellia psychrerythraea-type peptidase; ColAP), both members of the aminopeptidase M1 family. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase is poorly understood while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals. It accepts a variety of substrates, including some opioid, di- and tripeptides, as well as chromogenic aminoacyl-p-nitroanilide derivatives. The aminopeptidase activity of LTA4H is possibly involved in the processing of peptides related to inflammation and host defense. Kinetic analysis shows that LTA4H hydrolyzes arginyl tripeptides with high efficiency and specificity, indicating its function as an arginyl aminopeptidase. Thermodynamic characterization using different biophysical methods shows that structurally distinct inhibitors of the LTA4H occupy different regions of the binding site; while some (RB202, ARM1 and SC57461A) bind to the hydrophobic hydrolase side, both bestatin and captopril are located at the hydrophilic peptidase side. LTB4H overexpression is associated with different pathological conditions and diseases such as cystic fibrosis, coronary heart disease, sepsis, shock, connective tissue disease, and chronic obstructive pulmonary disease. It is also overexpressed in certain human cancers, and has been identified as a functionally important target for mediating anticancer properties of resveratrol, a well-known red wine polyphenolic compound with cancer chemopreventive activity.


Pssm-ID: 341062 [Multi-domain]  Cd Length: 442  Bit Score: 96.76  E-value: 3.84e-21
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 212 TQGETNLARQWFPGWDEPAFRPTYEVTAEVPQNWRVV-SnaAEKPSTNVGGGYKLVQFEKTPPMPSYLLFFGGGmfdtye 290
Cdd:cd09599  129 TQCQAIHARSLFPCQDTPSVKSTYSATVTVPKGLTALmS--ALRTGEKEEAGTGTYTFEQPVPIPSYLIAIAVG------ 200
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 291 dNFTSplpgAKGSLHLRVFTPPGMSDWAK------PAMDRTKQALDFYY---RYTGIPLPltkfdtvaanDAFKeqkdln 361
Cdd:cd09599  201 -DLES----REIGPRSGVWAEPSVVDAAAeefadtEKFLKAAEKLYGPYvwgRYDLLVLP----------PSFP------ 259
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 362 FGGMENwgSILEF------ADDIlpqpgqpmshYGNEVLTHEVAHQWFGDLVTTDWWDNVWLNESFATFFENKTTIQFFP 435
Cdd:cd09599  260 YGGMEN--PCLTFatptliAGDR----------SLVDVIAHEIAHSWSGNLVTNANWEHFWLNEGFTVYLERRILERLYG 327
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 436 DEF----------SWLDQVKNkyrvinrdIGPNAFP--VAPNFNDwasND----FvlsaSAFTYDKGGHVLKTLENYLGE 499
Cdd:cd09599  328 EEYrqfeailgwkDLQESIKE--------FGEDPPYtlLVPDLKG---VDpddaF----SSVPYEKGFQFLYYLEQLGGR 392
                        330
                 ....*....|....*.
gi 981344715 500 QTLRKGLQQYLVDYSF 515
Cdd:cd09599  393 EVFDPFLRAYFKKFAF 408
M1_APN cd09600
Peptidase M1 family, including aminopeptidase N catalytic domain; This model represents the ...
256-510 4.22e-16

Peptidase M1 family, including aminopeptidase N catalytic domain; This model represents the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. It includes bacterial-type alanyl aminopeptidases as well as PfA-M1 aminopeptidase (Plasmodium falciparum-type). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341063 [Multi-domain]  Cd Length: 434  Bit Score: 81.41  E-value: 4.22e-16
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 256 STNVGGGYKLVQFEKTPPMPSYLLFFGGGMFDTYEDNFTSPlPGAKgsLHLRVFTPPGMSDWAKPAMDRTKQALDFYYRY 335
Cdd:cd09600  157 EGELPNGRHFAVWEDPFPKPSYLFALVAGDLGSVEDTFTTK-SGRK--VKLRIYVEPGNEDKCHHAMESLKKAMKWDEER 233
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 336 TGIPLPLTKFDTVAANDafkeqkdLNFGGMENWG-----SILEFADdilPQPGQPMSHYGNE-VLTHEVAHQWFGDLVT- 408
Cdd:cd09600  234 FGLEYDLDLFNIVAVDD-------FNMGAMENKGlnifnSKYVLAD---PETATDADYERIEsVIAHEYFHNWTGNRVTc 303
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715 409 TDWWdNVWLNESFATFFENkttiQFFPDEFSwldqvknkyRVINR--------------DIGPNAFPVAP-------NFn 467
Cdd:cd09600  304 RDWF-QLSLKEGLTVFRDQ----EFSADMNS---------RAVKRiedvrrlrsaqfpeDAGPMAHPIRPdsyieinNF- 368
                        250       260       270       280
                 ....*....|....*....|....*....|....*....|...
gi 981344715 468 dwasndfvlsASAFTYDKGGHVLKTLENYLGEQTLRKGLQQYL 510
Cdd:cd09600  369 ----------YTVTVYEKGAEVIRMLHTLLGEEGFRKGMDLYF 401
leuko_A4_hydro TIGR02411
leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive ...
91-501 2.74e-13

leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive subset within the zinc metallopeptidase family M1 (pfam01433). The majority of the members of pfam01433 are aminopeptidases, but the sequences in this family for which the function is known are leukotriene A-4 hydrolase. A dual epoxide hydrolase and aminopeptidase activity at the same active site is indicated. The physiological substrate for aminopeptidase activity is not known.


Pssm-ID: 274120 [Multi-domain]  Cd Length: 602  Bit Score: 73.27  E-value: 2.74e-13
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715   91 GRADVEIKVLKP-VNNIVIAGHRIKFTNGRITLQPGNIQLIATPQDKGDFYQLRPAAGTiaPGNYSLHMEwsgiINFKSY 169
Cdd:TIGR02411  31 GSVTFTLKSLTDnLNKLVLDTSYLDIQKVTINGLPADFAIGERKEPLGSPLTISLPIAT--SKNDEFVLN----ISFSTT 104
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715  170 DDpvnhtggscgddpypgCSAAEGVfrvDLKSTDGTTSGAILTQGETNLARQWFPGWDEPAFRPTYEVTAEVPqnWRVVS 249
Cdd:TIGR02411 105 PK----------------CTALQWL---NPEQTSGKKHPYLFSQCQAIHARSLFPCQDTPSVKSTYTAEVESP--LPVLM 163
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715  250 NAAEKPSTNVGGGYKLvqFEKTPPMPSYLLFFGGGMFDTyednftSPLpGAKGSlhlrVFTPPGMSDwaKPAMDRTKQAL 329
Cdd:TIGR02411 164 SGIRDGETSNDPGKYL--FKQKVPIPAYLIAIASGDLAS------API-GPRST----VYSEPEQLE--KCQYEFENDTE 228
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715  330 DFYYRYTGIPLPL--TKFDTVAANDAFKeqkdlnFGGMENwgSILEFADDILPQPGQPMShygnEVLTHEVAHQWFGDLV 407
Cdd:TIGR02411 229 KFIKTAEDLIFPYewGQYDLLVLPPSFP------YGGMEN--PNLTFATPTLIAGDRSNV----DVIAHELAHSWSGNLV 296
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 981344715  408 TTDWWDNVWLNESFATFFENKTTIQFFPDEF-------SWLDqVKNKYRVINRDigPNAFPVAPNFNDWASNDfvlSASA 480
Cdd:TIGR02411 297 TNCSWEHFWLNEGWTVYLERRIIGRLYGEKTrhfsaliGWGD-LQESVKTLGET--PEFTKLVVDLKDNDPDD---AFSS 370
                         410       420
                  ....*....|....*....|.
gi 981344715  481 FTYDKGGHVLKTLENYLGEQT 501
Cdd:TIGR02411 371 VPYEKGFNFLFYLEQLLGGPA 391
GluZincin cd09594
Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, ...
363-429 9.24e-05

Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, M2, M3, M4, M13, M32 and M36 (fungalysins); The Gluzincin family (thermolysin-like peptidases or TLPs) includes several zinc-dependent metallopeptidases such as M1, M2, M3, M4, M13, M32, M36 peptidases (MEROPS classification), which contain the HEXXH motif as part of their active site. Peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. The M1 family includes aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity such that the two activities occupy different, but overlapping sites. The M3_like peptidases include the M2_ACE, M3 or neurolysin-like family (subfamilies M3B_PepF and M3A) and M32_Taq peptidases. The M2 peptidase angiotensin converting enzyme (ACE, EC 3.4.15.1) catalyzes the conversion of decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II. ACE is a key component of the renin-angiotensin system that regulates blood pressure, thus ACE inhibitors are important for the treatment of hypertension. M3A includes thimet oligopeptidase (TOP; endopeptidase 3.4.24.15), neurolysin (3.4.24.16), and the mitochondrial intermediate peptidase; and M3B includes oligopeptidase F. The M32 family includes eukaryotic enzymes from protozoa Trypanosoma cruzi, a causative agent of Chagas' disease, and from Leishmania major, a parasite that causes leishmaniasis, making these enzymes attractive targets for drug development. The M4 family includes secreted protease thermolysin (EC 3.4.24.27), pseudolysin, aureolysin, and neutral protease as well as bacillolysin (EC 3.4.24.28) that degrade extracellular proteins and peptides for bacterial nutrition, especially prior to sporulation. Thermolysin is widely used as a nonspecific protease to obtain fragments for peptide sequencing as well as in production of the artificial sweetener aspartame. The M13 family includes neprilysin (EC 3.4.24.11) and endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), which fulfill a broad range of physiological roles due to the greater variation in the S2' subsite allowing substrate specificity and are prime therapeutic targets for selective inhibition. The peptidase M36 fungalysin family includes endopeptidases from pathogenic fungi. Fungalysin hydrolyzes extracellular matrix proteins such as elastin and keratin. Aspergillus fumigatus causes the pulmonary disease aspergillosis by invading the lungs of immuno-compromised animals and secreting fungalysin that possibly breaks down proteinaceous structural barriers.


Pssm-ID: 341057 [Multi-domain]  Cd Length: 105  Bit Score: 42.09  E-value: 9.24e-05
                         10        20        30        40        50        60
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 981344715 363 GGMENWGSILEFADDILPQPGQpmshyGNEVLTHEVAHQWFGDLVTTDW-WDNVWLNESFATFFENKT 429
Cdd:cd09594   43 NAMWIPSTNIFYGAGILDTLSG-----TIDVLAHELTHAFTGQFSNLMYsWSSGWLNEGISDYFGGLV 105
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH